These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23711579)

  • 1. Short-term neonatal outcome among term infants after in utero exposure to serotonin reuptake inhibitors.
    Leibovitch L; Rymer-Haskel N; Schushan-Eisen I; Kuint J; Strauss T; Maayan-Metzger A
    Neonatology; 2013; 104(1):65-70. PubMed ID: 23711579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.
    Moses-Kolko EL; Bogen D; Perel J; Bregar A; Uhl K; Levin B; Wisner KL
    JAMA; 2005 May; 293(19):2372-83. PubMed ID: 15900008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
    Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
    Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.
    Oberlander TF; Bonaguro RJ; Misri S; Papsdorf M; Ross CJ; Simpson EM
    Mol Psychiatry; 2008 Jan; 13(1):65-73. PubMed ID: 17519929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.
    Smith MV; Sung A; Shah B; Mayes L; Klein DS; Yonkers KA
    Early Hum Dev; 2013 Feb; 89(2):81-6. PubMed ID: 22999988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
    Ferreira E; Carceller AM; Agogué C; Martin BZ; St-André M; Francoeur D; Bérard A
    Pediatrics; 2007 Jan; 119(1):52-9. PubMed ID: 17200271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome.
    Jordan AE; Jackson GL; Deardorff D; Shivakumar G; McIntire DD; Dashe JS
    J Matern Fetal Neonatal Med; 2008 Oct; 21(10):745-51. PubMed ID: 19012191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Term Neonatal Outcome among Term Infants after In-Utero Exposure to Beta Blockers.
    Mazkereth R; Maayan-Metzger A; Leibovitch L; Schushan-Eisen I; Morag I; Straus T
    Isr Med Assoc J; 2019 Nov; 21(11):724-727. PubMed ID: 31713359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.
    Salisbury AL; Wisner KL; Pearlstein T; Battle CL; Stroud L; Lester BM
    Depress Anxiety; 2011 Nov; 28(11):1008-19. PubMed ID: 21898709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
    van der Veere CN; Bos AF
    Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2873-4. PubMed ID: 18257430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications?
    Shea AK; Wang DY; Snelgrove JW; Dalfen A; Hewko S; Murphy KE
    J Obstet Gynaecol Can; 2021 Jun; 43(6):726-732. PubMed ID: 33303407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.
    Forsberg L; Navér L; Gustafsson LL; Wide K
    PLoS One; 2014; 9(11):e111327. PubMed ID: 25365553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study.
    Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
    Br J Psychiatry; 2008 May; 192(5):338-43. PubMed ID: 18450656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review.
    Fenger-Grøn J; Thomsen M; Andersen KS; Nielsen RG
    Dan Med Bull; 2011 Sep; 58(9):A4303. PubMed ID: 21893008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
    Sit D; Perel JM; Wisniewski SR; Helsel JC; Luther JF; Wisner KL
    J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal outcome and adaption after in utero exposure to antidepressants: A systematic review and meta-analysis.
    Kautzky A; Slamanig R; Unger A; Höflich A
    Acta Psychiatr Scand; 2022 Jan; 145(1):6-28. PubMed ID: 34486740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
    Yang A; Ciolino JD; Pinheiro E; Rasmussen-Torvik LJ; Sit DKY; Wisner KL
    J Clin Psychiatry; 2017 May; 78(5):605-611. PubMed ID: 28570796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.
    Levinson-Castiel R; Merlob P; Linder N; Sirota L; Klinger G
    Arch Pediatr Adolesc Med; 2006 Feb; 160(2):173-6. PubMed ID: 16461873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.